128 related articles for article (PubMed ID: 9707183)
1. Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study.
Haffner SM; D'Agostino R; Mykkänen L; Hales CN; Savage PJ; Bergman RN; O'Leary D; Rewers M; Selby J; Tracy R; Saad MF
Stroke; 1998 Aug; 29(8):1498-503. PubMed ID: 9707183
[TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study.
D'Agostino RB; Burke G; O'Leary D; Rewers M; Selby J; Savage PJ; Saad MF; Bergman RN; Howard G; Wagenknecht L; Haffner SM
Stroke; 1996 Oct; 27(10):1744-9. PubMed ID: 8841322
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Festa A; D'Agostino R; Mykkänen L; Tracy RP; Zaccaro DJ; Hales CN; Haffner SM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):562-8. PubMed ID: 10073958
[TBL] [Abstract][Full Text] [Related]
4. Insulin, insulin propeptides and intima-media thickness in the carotid artery in 58-year-old clinically healthy men. The Atherosclerosis and Insulin Resistance study (AIR).
Bokemark L; Wikstrand J; Wedel H; Fagerberg B;
Diabet Med; 2002 Feb; 19(2):144-51. PubMed ID: 11874431
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?
Temelkova-Kurktschiev T; Henkel E; Schaper F; Koehler C; Siegert G; Hanefeld M
Exp Clin Endocrinol Diabetes; 2000; 108(2):93-9. PubMed ID: 10826515
[TBL] [Abstract][Full Text] [Related]
6. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS).
Festa A; D'Agostino R; Rautaharju P; O'Leary DH; Rewers M; Mykkänen L; Haffner SM
Stroke; 1999 Aug; 30(8):1566-71. PubMed ID: 10436102
[TBL] [Abstract][Full Text] [Related]
7. Relationship of QT interval duration with carotid intima media thickness in a clinically healthy population undergoing cardiovascular risk screening.
Strohmer B; Pichler M; Iglseder B; Paulweber B
J Intern Med; 2005 Mar; 257(3):238-46. PubMed ID: 15715680
[TBL] [Abstract][Full Text] [Related]
8. Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS).
Wagenknecht LE; D'Agostino R; Savage PJ; O'Leary DH; Saad MF; Haffner SM
Stroke; 1997 May; 28(5):999-1005. PubMed ID: 9158641
[TBL] [Abstract][Full Text] [Related]
9. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
Howard G; O'Leary DH; Zaccaro D; Haffner S; Rewers M; Hamman R; Selby JV; Saad MF; Savage P; Bergman R
Circulation; 1996 May; 93(10):1809-17. PubMed ID: 8635260
[TBL] [Abstract][Full Text] [Related]
10. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
Wagenknecht LE; D'Agostino RB; Haffner SM; Savage PJ; Rewers M
Diabetes Care; 1998 Nov; 21(11):1812-8. PubMed ID: 9802726
[TBL] [Abstract][Full Text] [Related]
11. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).
Mykkänen L; Zaccaro DJ; O'Leary DH; Howard G; Robbins DC; Haffner SM
Stroke; 1997 Sep; 28(9):1710-6. PubMed ID: 9303013
[TBL] [Abstract][Full Text] [Related]
12. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance.
Bonora E; Tessari R; Micciolo R; Zenere M; Targher G; Padovani R; Falezza G; Muggeo M
Diabetes Care; 1997 Apr; 20(4):627-31. PubMed ID: 9096992
[TBL] [Abstract][Full Text] [Related]
13. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis.
Frauchiger B; Schmid HP; Roedel C; Moosmann P; Staub D
Stroke; 2001 Apr; 32(4):836-41. PubMed ID: 11283379
[TBL] [Abstract][Full Text] [Related]
14. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals.
Temelkova-Kurktschiev T; Koehler C; Schaper F; Henkel E; Hahnefeld A; Fuecker K; Siegert G; Hanefeld M
Diabetologia; 1998 Jun; 41(6):706-12. PubMed ID: 9662054
[TBL] [Abstract][Full Text] [Related]
15. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
[TBL] [Abstract][Full Text] [Related]
16. Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
Mellen PB; Liese AD; Tooze JA; Vitolins MZ; Wagenknecht LE; Herrington DM
Am J Clin Nutr; 2007 Jun; 85(6):1495-502. PubMed ID: 17556684
[TBL] [Abstract][Full Text] [Related]
17. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.
Hanefeld M; Koehler C; Henkel E; Fuecker K; Schaper F; Temelkova-Kurktschiev T
Diabet Med; 2000 Dec; 17(12):835-40. PubMed ID: 11168325
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects.
Zhang YF; Hong J; Zhan WW; Li XY; Gu WQ; Yang YS; Xu M; Ning G
Clin Endocrinol (Oxf); 2006 Feb; 64(2):153-7. PubMed ID: 16430713
[TBL] [Abstract][Full Text] [Related]
19. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.
Haffner SM; D'Agostino R; Saad MF; Rewers M; Mykkänen L; Selby J; Howard G; Savage PJ; Hamman RF; Wagenknecht LE
Diabetes; 1996 Jun; 45(6):742-8. PubMed ID: 8635647
[TBL] [Abstract][Full Text] [Related]
20. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
